Kjell Olmarker

Corporate Officer/Principal presso University of Gothenburg

66 anni

Health Technology

Consumer Services

Posizioni attive di Kjell Olmarker

Società	Posizione	Inizio	Fine
University of Gothenburg	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
STAYBLE THERAPEUTICS AB	Direttore/Membro del Consiglio	01/01/2015	-
STAYBLE THERAPEUTICS AB	Fondatore	01/01/2015	-
PharmaSurgics In Sweden AB PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established.	Direttore/Membro del Consiglio	01/01/2005	-
	Fondatore	01/12/2009	-

Distribuzione geografica

Svezia

Posizioni

Director/Board Member	2
Founder	2
Corporate Officer/Principal	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
STAYBLE THERAPEUTICS AB	Health Technology

Aziende private	1
PharmaSurgics In Sweden AB PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established.	Health Technology

Aziende private

Health Technology